Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C

Digestive and Liver Disease

Volumn 43, Issue 10, 2011, Pages 807-813

  Ferri, Silvia ^a   Lalanne, Claudine ^a   Lanzoni, Giulia ^a   Bassi, Mirna ^b   Asioli, Sofia ^c   Cipriano, Valentina ^a   Pappas, Georgios ^a   Muratori, Paolo ^a   Lenzi, Marco ^a   Muratori, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic HCV related liver disease; Decompensated cirrhosis; MELD score; Regulatory T cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELLS, CULTURED; END STAGE LIVER DISEASE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GAMMA-GLUTAMYLTRANSFERASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-GAMMA; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 80052468549     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.04.020     Document Type: Article

References (40)

1. Seeff L.B. The history of the "natural history" of hepatitis C (1968-2009). Liver Int 2009, 29(Suppl. 1):89-99.
2. Castello G., Scala S., Palmieri G., et al. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol 2010, 134:237-250.
3. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
4. Diepolder H.M. New insights into the immunopathogenesis of chronic hepatitis C. Antiviral Res 2009, 82:103-109.
5. Barnaba V. Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival. J Hepatol 2010, 53:752-761.
6. Levings M.K., Allan S., d'Hennezel E., et al. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 2006, 92:119-155.
7. Lim H.W., Broxmeyer H.E., Kim C.H. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 2006, 177:840-851.
8. Sakaguchi S., Ono M., Setoguchi R., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
9. Shevach E.M., DiPaolo R.A., Andersson J., et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 2006, 212:60-73.
10. Manigold T., Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007, 7:804-813.
11. Piccirillo C.A. Regulatory T cells in health and disease. Cytokine 2008, 43:395-401.
12. Perrella A., Vitiello L., Atripaldi L., et al. Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. Gut 2006, 55:1370-1371.
13. Sugimoto K., Ikeda F., Stadanlick J., et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003, 38:1437-1448.
14. Ulsenheimer A., Gerlach J.T., Gruener N.H., et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003, 37:1189-1198.
15. Heeg M.H., Ulsenheimer A., Gruner N.H., et al. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 2009, 137. 1280-8.e1-6.
16. Boettler T., Spangenberg H.C., Neumann-Haefelin C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005, 79:7860-7867.
17. Bolacchi F., Sinistro A., Ciaprini C., et al. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006, 144:188-196.
18. Cabrera R., Tu Z., Xu Y., et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004, 40:1062-1071.
19. Ebinuma H., Nakamoto N., Li Y., et al. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 2008, 82:5043-5053.
20. Sturm N., Thelu M.A., Camous X., et al. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. J Hepatol 2010, 53:25-35.
21. Ward S.M., Fox B.C., Brown P.J., et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 2007, 47:316-324.
22. Fu J., Xu D., Liu Z., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
23. Gao Q., Qiu S.J., Fan J., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007, 25:2586-2593.
24. Kobayashi N., Hiraoka N., Yamagami W., et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007, 13:902-911.
25. Ormandy L.A., Hillemann T., Wedemeyer H., et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005, 65:2457-2464.
26. Yang X.H., Yamagiwa S., Ichida T., et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 2006, 45:254-262.
27. Yoshizawa K., Abe H., Kubo Y., et al. Expansion of CD4(+)CD25(+)FoxP3(+) regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res 2010, 40:179-187.
28. Matsumoto Y., Horiike S., Ohshiro M., et al. Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis. Am J Clin Pathol 2010, 133:281-290.
29. Itose I., Kanto T., Kakita N., et al. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis. J Viral Hepat 2009, 16:844-852.
30. Xu D., Fu J., Jin L., et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177:739-747.
31. Qamar A.A., Grace N.D. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009, 23:441-445.
32. Spengler U., Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin Sci (Lond) 2007, 112:141-155.
33. Dumoulin F.L., Bach A., Leifeld L., et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997, 175:681-685.
34. Napoli J., Bishop G.A., McGuinness P.H., et al. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996, 24:759-765.
35. Hall C.H., Kassel R., Tacke R.S., et al. HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS One 2010, 5:e12154.
36. Garaigorta U., Chisari F.V., Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 2009, 6:513-522.
37. Lechner F., Wong D.K., Dunbar P.R., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000, 191:1499-1512.
38. Wedemeyer H., He X.S., Nascimbeni M., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002, 169:3447-3458.
39. Patzwahl R., Meier V., Ramadori G., et al. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 2001, 75:1332-1338.
40. Okamoto T., Yamamura K., Hino O. The mouse interferon-gamma transgene chronic hepatitis model (review). Int J Mol Med 1999, 3:517-520.